It's an interesting debate.
To get bought out or not to?
There almost seems to be a stigma about the thought of getting bought out early in a game.
'It's better to wait until we progress further'
'It's too cheap'
'I wouldn't accept that price'
All the common debates, but is it.
Biotech is so fragile and even the best of techs and companies can fall over for all sorts of reasons.
So why not have mission accomplished early?
Is it people at these companies lose their jobs?
Sometimes you make hay when the sun shine.
Anywhere between $3-$5 should be jumped at.
It's an interesting debate. To get bought out or not to? There...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B | |||
| Open | High | Low | Value | Volume |
| $15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 696 | $15.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.67 | 6942 | 8 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |